Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
株式のランク #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
株価
$0.1
最終同期: 2024-06-18
時価総額
$1.31M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Pascal Biosciences Inc. (PSCBF)

カテゴリー

Pascal Biosciences Inc.(PSCBF)のP/E比率
August 2026 時点のP/E比率 TTM -9.11
Pascal Biosciences Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は -9.11 です。2022 年末時点での P/E は -2.82 でした。
Pascal Biosciences Inc. の P/E 比率の履歴(2019 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) -9.11 127.77%
2023 -4.00 42.00%
2022 -2.82 33,029.41%
2021 -0.01 8,400.00%
2020 0.00 0.00%
2019 0.00 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
28.05 -407.86%
US
31.14 -441.84%
NL
- -
CH
- -
KR
19.30 -311.82%
BE
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。